ALISON ROBBINS: Open Payments
NPI 1164862710 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 58 payments from 18 companies in 2025. Trend: 2023 $1,118 · 2024 $1,476 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $379 |
| GENZYME CORPORATION | 10 | $326 |
| GlaxoSmithKline, LLC. | 9 | $243 |
| Viatris Specialty LLC | 6 | $111 |
| Insmed, Inc. | 4 | $83 |
| Verona Pharma, Inc. | 3 | $82 |
| Grifols USA, LLC | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $77 |
| HARMONY BIOSCIENCES LLC | 1 | $49 |
| Baxter Healthcare | 2 | $43 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, AIRSUPRA, YUPELRI, FASENRA, Arikayce, Ohtuvayre.
Industry payments across GA — which companies pay providers there.
